National Centre for Rare Diseases, Istituto Superiore di Sanità, Viale Regina Elena, Rome, Italy.
Adv Exp Med Biol. 2010;686:475-91. doi: 10.1007/978-90-481-9485-8_26.
This analysis of national plans and strategies on RD in Europe shows that a few countries have already set up national plans. Existing national plans show a good consistency, but also a quite different stage of progress, depending on start date as well as on resource allocation. Several other EU countries have launched actions on RD, often with a considerable strategic effort; however, such initiatives are yet not integrated in a consistent national strategy taking into account the EC recommendations. The project EUROPLAN represents a major initiative to support the development of a shared strategy on RD at EU and Member State level; critical steps include the comparative evaluation of existing plans and actions, identification of gaps and achievements, the development of consensus indicators, as well as the integration of successful national achievements within the EU strategy.
本分析国家计划和战略研发在欧洲表明,有几个国家已经建立了国家计划。现有的国家计划表现出很好的一致性,但也有相当不同的阶段进展,这取决于开始日期以及资源分配。其他几个欧盟国家已经开展了研发行动,往往需要相当大的战略努力;然而,这些举措尚未纳入一致的国家战略,考虑到欧共体的建议。项目 EUROPLAN 代表了一个重大举措,以支持制定在欧盟和成员国一级的研发共享战略;关键步骤包括对现有计划和行动的比较评估,确定差距和成就,制定共识指标,以及将成功的国家成就纳入欧盟战略。